Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy (Q33844109)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy |
scientific article |
Statements
1 reference
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
Srdan Verstovsek
1 reference
William G Wierda
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Elias Jabbour
1 reference
Mary Beth Rios
1 reference
Guillermo Garcia-Manero
1 reference
Jenny Shan
1 reference
Neeli Reddy
1 reference
Dan Jones
1 reference
5 December 2008
1 reference
1 reference
113
1 reference
10
1 reference
2154-2160
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference